Genpharmasec Ltd
GENPHARMAGenpharmasec Ltd
GENPHARMAPrice Chart
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
— | 2.03 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
53.76 | 8.00 | 0.41% |
Forecast & Ratings
Detailed ForecastPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Generic Pharmasec Ltd is an India-based company. The Company is focused on trading and dealing in chemicals.
Peers
Compare with peersAdani Enterprises Ltd
MMTC Ltd
MSTC Ltd
Lloyds Enterprises Ltd
Veritas (India) Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Revenue Forecast
Earnings Per Share Forecast
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 0.21 | 0.55 | 0.17 | 0.75 | 17.06 | 21.64 | 27.41 | 25.62 | 31.07 | — | ||||||||||
Raw Materials | 0.00 | 0.42 | 0.00 | 5.25 | 13.45 | 23.42 | 28.77 | 23.18 | 23.40 | — | ||||||||||
Power & Fuel Cost | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||
Employee Cost | 0.01 | 0.01 | 0.02 | 0.02 | 0.13 | 0.19 | 0.25 | 0.54 | 0.76 | |||||||||||
Selling & Administrative Expenses | 0.09 | 0.10 | 0.08 | 0.39 | 0.41 | 0.55 | 0.82 | 0.95 | 3.36 | |||||||||||
Operating & Other expenses | 0.01 | 0.01 | 0.01 | -5.20 | 1.87 | -4.05 | -2.00 | 0.58 | 2.84 | |||||||||||
EBITDA | 0.10 | 0.01 | 0.06 | 0.29 | 1.20 | 1.53 | -0.43 | 0.37 | 0.71 | — | ||||||||||
Depreciation/Amortization | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 | 0.04 | — | ||||||||||
PBIT | 0.10 | 0.01 | 0.06 | 0.29 | 1.20 | 1.52 | -0.44 | 0.35 | 0.67 | — | ||||||||||
Interest & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 | 0.41 | — | ||||||||||
PBT | 0.10 | 0.01 | 0.06 | 0.29 | 1.20 | 1.52 | -0.44 | 0.29 | 0.26 | — | ||||||||||
Taxes & Other Items | 0.00 | 0.00 | 0.02 | 0.06 | 0.20 | 0.25 | -0.23 | -0.84 | 0.38 | — | ||||||||||
Net Income | 0.10 | 0.01 | 0.04 | 0.23 | 1.00 | 1.27 | -0.21 | 1.13 | -0.12 | — | ||||||||||
EPS | 0.01 | 0.00 | 0.07 | 0.01 | 0.03 | 0.03 | -0.00 | 0.02 | -0.00 | — | ||||||||||
DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||||
Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Company Updates
Investor Presentation
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
IndustrialsCommodities Trading
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Genpharmasec Ltd | -1,093.60 | 2.03 | — |
Adani Enterprises Ltd | 112.29 | 8.23 | 0.04% |
MMTC Ltd | 66.86 | 9.10 | — |
MSTC Ltd | 30.16 | 7.84 | 1.20% |
Price Comparison
Compare GENPHARMA with any stock or ETFShareholdings
Promoter Holdings Trend
Decreased Total Promoter Holding
In last 6 months, promoter holding in the company has decreased by 29.98%
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Sep 2023
Dec 2023
Feb 2024
Mar 2024
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
GENPHARMA has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
News & Opinions
Generic Pharmasec reports standalone net loss of Rs 0.61 crore in the September 2021 quarter
2 years ago•Business Standard
Generic Pharmasec Ltd. successfully executes an order from Reliance Group
2 years ago•Business Standard
Generic Pharmasec successfully executes order from Reliance Group
2 years ago•India Infoline
Generic Pharmasec standalone net profit rises 445.65% in the March 2021 quarter
3 years ago•Business Standard
Generic Pharmasec enters into agreement with Abbott Point of Care (APOC)
3 years ago•India Infoline
Generic Pharmasec standalone net profit declines 80.00% in the December 2020 quarter
3 years ago•Business Standard
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 110.6%, vs industry avg of 4.43%
Increasing Market Share
Over the last 5 years, market share increased from 0% to 0.02%